BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 22, 2026
Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 29, 2014

View Archived Issues

China's cross-border partnering deals set to break record in 2014

SUZHOU, China – The China growth story continues to buoy the life science industry, even in the face of challenging headwinds of change. That was the message from PwC experts who extensively surveyed executives and innovators across device, service, venture capital and pharma, many of whom were in the room for the recent collegial ChinaBio Leadership Retreat in Changshu. Read More

All hands on deck as Korea aims to regain stem cell leadership position

SEOUL, South Korea – South Korean companies focused on research and development of stem cell therapy products are working hard to put the country back into a position of global leadership, even after setbacks in the last decade that held back research for years. Read More

For Ebola victory, scientific advances could help with nonscientific challenges

From a purely scientific standpoint, the news about the Ebola outbreak has been encouraging. New genomic technologies enable unprecedented surveillance of the virus. There are drugs and vaccines in clinical trials. And in response to the urgency of the crisis, both drugmakers and regulatory agencies are making efforts to expedite the process of getting weapons against Ebola through the regulatory process and into the field, where they are needed. Read More

Transplanted stem cells release dopamine in PD model, study shows

HONG KONG – Chinese researchers have demonstrated that grafted neural stem cells directly release dopamine into the damaged striata of rat brains in vivo and partially rescued a model of Parkinson's disease (PD), providing proof of concept for the feasibility of that technique for treating PD in humans. Read More

Asian vaccine makers are picking up the pace

SEOUL, South Korea – Vaccine makers in Asian emerging markets are stepping up their development efforts, while researchers are increasingly helping developing countries troubled by neglected diseases by partnering with domestic manufactures, often in neighboring countries. Read More

Other news to note

Twi Pharmaceuticals Inc., of Taipei, Taiwan, said its subsidiary, Twi Biotechnology Inc., gained FDA orphan drug status for AC-201, a drug it is developing for rare genetic connective tissue disorder epidermolysis bullosa, a pediatric disorder that leaves children with fragile skin that blisters and tears from friction or trauma. Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing